Basingab F, Alshahrani O, Alansari I, Almarghalani N, Alshelali N, Alsaiary A
Breast Cancer (Dove Med Press). 2025; 17:27-51.
PMID: 39867813
PMC: 11761866.
DOI: 10.2147/BCTT.S501448.
Elsafy S, Metselaar J, Lammers T
Handb Exp Pharmacol. 2023; 284:231-265.
PMID: 37578622
DOI: 10.1007/164_2023_685.
Sarkar S, Banerjee A, Bandopadhyay R
Appl Biochem Biotechnol. 2023; 196(5):2466-2486.
PMID: 37477844
DOI: 10.1007/s12010-023-04648-x.
Khil N, Sharma S, Sharma P, Alam A
Curr Mol Med. 2023; 24(9):1077-1090.
PMID: 37475554
DOI: 10.2174/1566524023666230720110351.
Pandey S, Shaikh F, Gupta A, Tripathi P, Yadav J
Adv Pharm Bull. 2022; 12(1):17-33.
PMID: 35517874
PMC: 9012924.
DOI: 10.34172/apb.2022.007.
A brief review on solid lipid nanoparticles: part and parcel of contemporary drug delivery systems.
Duan Y, Dhar A, Patel C, Khimani M, Neogi S, Sharma P
RSC Adv. 2022; 10(45):26777-26791.
PMID: 35515778
PMC: 9055574.
DOI: 10.1039/d0ra03491f.
Modulation of Chitosan-TPP Nanoparticle Properties for Plasmid DNA Vaccines Delivery.
Nunes R, Serra A, Simaite A, Sousa A
Polymers (Basel). 2022; 14(7).
PMID: 35406316
PMC: 9003200.
DOI: 10.3390/polym14071443.
Protein Nanoparticles: Uniting the Power of Proteins with Engineering Design Approaches.
Habibi N, Mauser A, Ko Y, Lahann J
Adv Sci (Weinh). 2022; 9(8):e2104012.
PMID: 35077010
PMC: 8922121.
DOI: 10.1002/advs.202104012.
Solid Lipid Nanoparticles (SLNs): An Advanced Drug Delivery System Targeting Brain through BBB.
Satapathy M, Yen T, Jan J, Tang R, Wang J, Taliyan R
Pharmaceutics. 2021; 13(8).
PMID: 34452143
PMC: 8402065.
DOI: 10.3390/pharmaceutics13081183.
Electromagnetically Stimuli-Responsive Nanoparticles-Based Systems for Biomedical Applications: Recent Advances and Future Perspectives.
Longo R, Gorrasi G, Guadagno L
Nanomaterials (Basel). 2021; 11(4).
PMID: 33810343
PMC: 8065448.
DOI: 10.3390/nano11040848.
Protein-Based Nanoparticles as Drug Delivery Systems.
Hong S, Choi D, Kim H, Park C, Lee W, Park H
Pharmaceutics. 2020; 12(7).
PMID: 32610448
PMC: 7407889.
DOI: 10.3390/pharmaceutics12070604.
Ocular Drug, Gene and Cellular Delivery Systems and Advanced Therapy Medicinal Products.
Eldem T, Eldem B
Turk J Ophthalmol. 2018; 48(3):132-141.
PMID: 29988818
PMC: 6032955.
DOI: 10.4274/tjo.32458.
Therapeutic prospects of microRNAs in cancer treatment through nanotechnology.
Awasthi R, Rathbone M, Hansbro P, Bebawy M, Dua K
Drug Deliv Transl Res. 2017; 8(1):97-110.
PMID: 29185148
DOI: 10.1007/s13346-017-0440-1.
Biopolymeric nanoparticles.
Sundar S, Kundu J, Kundu S
Sci Technol Adv Mater. 2016; 11(1):014104.
PMID: 27877319
PMC: 5090546.
DOI: 10.1088/1468-6996/11/1/014104.
Surface Modified Multifunctional and Stimuli Responsive Nanoparticles for Drug Targeting: Current Status and Uses.
Siafaka P, Ustundag Okur N, Karavas E, Bikiaris D
Int J Mol Sci. 2016; 17(9).
PMID: 27589733
PMC: 5037719.
DOI: 10.3390/ijms17091440.
Engineering solid lipid nanoparticles for improved drug delivery: promises and challenges of translational research.
Mishra D, Dhote V, Bhatnagar P, Mishra P
Drug Deliv Transl Res. 2015; 2(4):238-53.
PMID: 25787030
DOI: 10.1007/s13346-012-0088-9.
Nanoparticles in relation to peptide and protein aggregation.
Zaman M, Ahmad E, Qadeer A, Rabbani G, Khan R
Int J Nanomedicine. 2014; 9:899-912.
PMID: 24611007
PMC: 3928455.
DOI: 10.2147/IJN.S54171.
Nanotechnology in cancer therapy.
Aslan B, Ozpolat B, Sood A, Lopez-Berestein G
J Drug Target. 2013; 21(10):904-13.
PMID: 24079419
PMC: 4057038.
DOI: 10.3109/1061186X.2013.837469.
Biodistribution and renal clearance of biocompatible lung targeted poly(ethylene glycol) (PEG) nanogel aggregates.
Deshmukh M, Kutscher H, Gao D, Sunil V, Malaviya R, Vayas K
J Control Release. 2012; 164(1):65-73.
PMID: 23041417
PMC: 3858961.
DOI: 10.1016/j.jconrel.2012.09.011.
Strategies in the design of nanoparticles for therapeutic applications.
Petros R, DeSimone J
Nat Rev Drug Discov. 2010; 9(8):615-27.
PMID: 20616808
DOI: 10.1038/nrd2591.
